71 related articles for article (PubMed ID: 9428921)
1. HLA binding characteristics and generation of cytotoxic lymphocytes against peptides derived from oncogenic proteins.
Bertazzoli C; Marchesi E; Dermime S; Ravagnani F; Parmiani G; Gambacorti-Passerini C
Tumori; 1997; 83(5):847-55. PubMed ID: 9428921
[TBL] [Abstract][Full Text] [Related]
2. Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancers.
Gambacorti-Passerini C; Bertazzoli C; Dermime S; Scardino A; Schendel D; Parmiani G
Clin Cancer Res; 1997 May; 3(5):675-83. PubMed ID: 9815736
[TBL] [Abstract][Full Text] [Related]
3. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
[TBL] [Abstract][Full Text] [Related]
4. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
5. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
[TBL] [Abstract][Full Text] [Related]
6. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
Peng W; Huang X; Yang D
Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
[TBL] [Abstract][Full Text] [Related]
7. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
[TBL] [Abstract][Full Text] [Related]
8. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
[TBL] [Abstract][Full Text] [Related]
9. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
[TBL] [Abstract][Full Text] [Related]
10. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
Bristol JA; Schlom J; Abrams SI
J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
[TBL] [Abstract][Full Text] [Related]
11. HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes.
Gjertsen MK; Saeterdal I; Saebøe-Larssen S; Gaudernack G
J Mol Med (Berl); 2003 Jan; 81(1):43-50. PubMed ID: 12545248
[TBL] [Abstract][Full Text] [Related]
12. Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes.
Buzyn A; Ostankovitch M; Zerbib A; Kemula M; Connan F; Varet B; Guillet JG; Choppin J
Eur J Immunol; 1997 Aug; 27(8):2066-72. PubMed ID: 9295046
[TBL] [Abstract][Full Text] [Related]
13. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
Umano Y; Tsunoda T; Tanaka H; Matsuda K; Yamaue H; Tanimura H
Br J Cancer; 2001 Apr; 84(8):1052-7. PubMed ID: 11308253
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T-lymphocyte responses against mutated p21 ras peptides: an analysis of specific T-cell-receptor gene usage.
Juretic A; Jürgens-Göbel J; Schaefer C; Noppen C; Willimann TE; Kocher T; Zuber M; Harder F; Heberer M; Spagnoli GC
Int J Cancer; 1996 Nov; 68(4):471-8. PubMed ID: 8945618
[TBL] [Abstract][Full Text] [Related]
15. Differential binding to frequent HLA-A alleles of p21 RAS derived peptides bearing oncogenic substitutions at position 12 or 13.
Gouttefangeas C; Demeur C; Connan F; Balayn N; Choppin J; Tilkin-Mariamé AF
Hum Immunol; 1997 Jul; 55(2):117-26. PubMed ID: 9361963
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of mouse monoclonal antibodies to wild-type and oncogenic FLI-1 proteins.
Melot T; Gruel N; Doubeikovski A; Sevenet N; Teillaud JL; Delattre O
Hybridoma; 1997 Oct; 16(5):457-64. PubMed ID: 9388029
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.
Jelachich ML; Cowan EP; Turner RV; Coligan JE; Biddison WE
J Immunol; 1988 Aug; 141(4):1108-13. PubMed ID: 2456340
[TBL] [Abstract][Full Text] [Related]
18. Improved generation of HLA class I/peptide tetramers.
Sato Y; Sahara H; Tsukahara T; Kondo M; Hirohashi Y; Nabeta Y; Kawaguchi S; Ikeda H; Torigoe T; Ichimiya S; Tamura Y; Wada T; Yamashita T; Goto M; Takasu H; Sato N
J Immunol Methods; 2002 Dec; 271(1-2):177-84. PubMed ID: 12445740
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocytes that recognize decameric peptide sequences of retinoblastoma binding protein 1 (RBP-1) associated with human breast cancer.
Takahashi T; Cao J; Hoon DS; Irie RF
Br J Cancer; 1999 Sep; 81(2):342-9. PubMed ID: 10496363
[TBL] [Abstract][Full Text] [Related]
20. T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides.
Gedde-Dahl T; Eriksen JA; Thorsby E; Gaudernack G
Hum Immunol; 1992 Apr; 33(4):266-74. PubMed ID: 1639630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
